For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Simvastatin | Simvastatin 80 mg | None | None | 0 | 30 | 3 | 30 | View |
| Eslicarbazepine Acetate | eslicarbazepine acetate 800 mg | None | None | 0 | 30 | 23 | 30 | View |
| Eslicarbazepine Acetate + Simvastatin | Simvastatin 80 mg + eslicarbazepine acetate 800 mg | None | None | 0 | 30 | 5 | 30 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal pain upper | None | Gastrointestinal disorders | None | View |
| Diarrhoea | None | Gastrointestinal disorders | None | View |
| Vomiting | None | Gastrointestinal disorders | None | View |
| Asthenia | None | General disorders | None | View |
| Fatigue | None | General disorders | None | View |
| Cystitis | None | Infections and infestations | None | View |
| Pharyngitis | None | Infections and infestations | None | View |
| Joint sprain | None | Injury, poisoning and procedural complications | None | View |
| Transaminases increased | None | Investigations | None | View |
| Neck pain | None | Musculoskeletal and connective tissue disorders | None | View |
| Lymphadenopathy | None | Blood and lymphatic system disorders | None | View |
| Disturbance in attention | None | Nervous system disorders | None | View |
| Dizziness | None | Nervous system disorders | None | View |
| Dizziness postural | None | Nervous system disorders | None | View |
| Headache | None | Nervous system disorders | None | View |
| Nightmare | None | Psychiatric disorders | None | View |
| Oropharyngeal pain | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Pruritus | None | Skin and subcutaneous tissue disorders | None | View |
| Rash erythematous | None | Skin and subcutaneous tissue disorders | None | View |
| Rash morbilliform | None | Skin and subcutaneous tissue disorders | None | View |
| Rash papular | None | Skin and subcutaneous tissue disorders | None | View |
| Urticaria | None | Skin and subcutaneous tissue disorders | None | View |
| Orthostatic hypotension | None | Vascular disorders | None | View |